Viewing Study NCT00292266


Ignite Creation Date: 2025-12-24 @ 4:09 PM
Ignite Modification Date: 2025-12-27 @ 1:12 PM
Study NCT ID: NCT00292266
Status: COMPLETED
Last Update Posted: 2013-08-05
First Post: 2006-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)
Sponsor: EMD Serono
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module